Clinical Trial Update: AAR/AAR+HAR vs AAR+TAR+FET for Type A Aortic Intramural Hematoma [NA]

View source ↗

Summary

This clinical trial compares surgical strategies for Type A aortic intramural hematoma (AAR/AAR+HAR vs AAR+TAR+FET) and is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Intramural Hematoma

Snippet

Sponsor: Second Hospital of Jilin University | Conditions: Aortic Intramural Hematoma | NA | Status: NOT_YET_RECRUITING